New Brunswick’s Johnson & Johnson (NYSE: JNJ) said Thursday its pharmaceutical research and dNew Brunswick”s Johnson & Johnson (NYSE: JNJ) said Thursday its pharmaceutical research and d
FDA Rejects JJ’s Risperdal for Alzheimer’s-Related Psychosis
NJBIZ Business Events
NJBIZ Healthcare Heroes 2022
Wednesday, August 10, 2022
2022 NJBIZ Panel Discussion: Diversity, Equity, Inclusion in the Workplace
Tuesday, August 23, 2022
NJBIZ Connect Networking Event
Tuesday, September 13, 2022
NJBIZ Forty Under 40 Awards 2022
Wednesday, September 21, 2022
